Article
The Impact of CRISPR-Cas System on Antiviral Therapy
29 Nov 2018
Abstract excerpt
Clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein nuclease (Cas) is identified as an adaptive immune system in archaea and bacteria. Type II of this system, CRISPR-Cas9, is the most versatile form that has enabled facile and efficient targeted genome editing. Viral infections have serious impacts on global health and conventional antiviral therapies have not yielded a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
